EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer

Kebang Hu iD, Dongqi Zhang, Weiran Ma iD, Yanzhi Gu, Jiang Zhao iD, Xupeng Mu iD

International Journal of Nanomedicine · 2024-07 · Volume 19 · 6717-6730

DOI: 10.2147/ijn.s468946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024-07. Verfasst von Kebang Hu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Lequn Branch, The First Hospital of Jilin University, Changchun, 130031, People's Republic of China. Hauptthemen laut MEDLINE: Doxorubicin, Indoles, Polymers, Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinIndolesPolymersProstatic NeoplasmsNanoparticlesApoptosisAzepinesMaleAnimalsHumansMiceCell Line, TumorDrug SynergismCell SurvivalTissue DistributionXenograft Model Antitumor AssaysDrug LiberationDrug CarriersB7-H1 AntigenTriazoles

Stichwörter der Autor:innen

JQ1PD-L1chemotherapydoxorubicinpolydopamineprostate cancer

Substanzen

polydopamineDoxorubicinIndolesPolymersAzepines(+)-JQ1 compoundDrug CarriersB7-H1 AntigenTriazoles

Autor:innen und Institutionen

  • Department of Urology, Lequn Branch, The First Hospital of Jilin University, Changchun, 130031, People's Republic of China.
  • College of Pharmacy, Jilin University, Changchun, 130021, People's Republic of China.
  • Department of Urology, Xi'an First Hospital, Xi'an, 710002, People's Republic of China.
  • Scientific Research Center, China-Japan Union Hospital of Jilin University, Changchun, 130033, People's Republic of China.

ORCID-Profile: Kebang Hu, Weiran Ma, Jiang Zhao, Xupeng Mu

Zitieren

APA

Hu, K., Zhang, D., Ma, W., Gu, Y., Zhao, J., & Mu, X. (2024). Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer. International Journal of Nanomedicine, Volume 19, 6717-6730. https://doi.org/10.2147/ijn.s468946

Vancouver

Hu K, Zhang D, Ma W, Gu Y, Zhao J, Mu X. Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer. International Journal of Nanomedicine. 2024;Volume 19:6717-6730. doi:10.2147/ijn.s468946

BibTeX
@article{Hu2024,
  author = {Hu, Kebang and Zhang, Dongqi and Ma, Weiran and Gu, Yanzhi and Zhao, Jiang and Mu, Xupeng},
  title = {Polydopamine-Based Nanoparticles for Synergistic Chemotherapy of Prostate Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  volume = {Volume 19},
  pages = {6717--6730},
  doi = {10.2147/ijn.s468946}
}
Kostenlos starten →